Cutler Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Cutler Group’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,500	Closed	-$9K	–	5506
2020 Q2	$9K	Sell	2,500 -7,300	-74%	-$609K	﹤0.01%	2982
2020 Q1	$251K	Buy	9,800 +9,200	+1,533%	+$590K	0.01%	835
2019 Q4	$6K	Buy	+600	New	+$36.4K	﹤0.01%	3000
2019 Q3	–	Sell	-3,000	Closed	-$8K	–	4975
2019 Q2	$8K	Buy	3,000 +500	+20%	+$24.3K	﹤0.01%	2869
2019 Q1	$3K	Buy	+2,500	New	+$115K	﹤0.01%	3298
2018 Q3	–	Sell	-3,000	Closed	-$8K	–	4979
2018 Q2	$8K	Sell	3,000 -15,000	-83%	-$726K	﹤0.01%	2859
2018 Q1	$55K	Buy	+18,000	New	+$936K	﹤0.01%	1603

Cutler Group's MYOK Position: Q3 2019 in Review

Cutler Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2019, closing a stake of 97 shares — an estimated $4K sold.

Cutler Group first reported a position in MYOK in Q4 2017 and held it in 5 quarters. The position peaked at $492K in Q1 2018. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

Cutler Group reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Cutler Group sold 97 MyoKardia, Inc. Common Stock shares in Q3 2019, an estimated $4K.
Cutler Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
Cutler Group's MyoKardia, Inc. Common Stock position peaked at $492K in Q1 2018.
157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Cutler Group's 13F filing for Q3 2019, filed 28 Oct 2019.